Is oral combination therapy with a proton-pump inhibitor and H2 receptor antagonist effective as initial treatment?
Inamori
Masahiko
M
Akimoto
Keiko
K
Akiyama
Tomoyuki
T
Fujita
Koji
K
Takahashi
Hirokazu
H
Yoneda
Masato
M
Abe
Yasunobu
Y
Kirikoshi
Hiroyuki
H
Kubota
Kensuke
K
Saito
Satoru
S
Ueno
Norio
N
Nakajima
Atsushi
A
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000008:administration & dosage*; D000081:Acetamides / Q000008:administration & dosage*; D000284:Administration, Oral; D000328:Adult; D004359:Drug Therapy, Combination; D006635:Histamine H2 Antagonists / Q000008:administration & dosage*; D006801:Humans; D064747:Lansoprazole; D008297:Male; D010880:Piperidines / Q000008:administration & dosage*; D054328:Proton Pump Inhibitors; D011725:Pyridines / Q000008:administration & dosage*
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000081:Acetamides; D006635:Histamine H2 Antagonists; D010880:Piperidines; D054328:Proton Pump Inhibitors; D011725:Pyridines; D064747:Lansoprazole; C076948:lafutidine